Last reviewed · How we verify
NCT03859232
Effectiveness of Cotton vs. Waterproof Cast Padding
NA trial testing Delta Dry® Waterproof Pantaloon in Developmental Dysplasia of the Hip. Withdrawn.
28 March 2022
Quick facts
| Lead sponsor | Baylor College of Medicine |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Start date | 29 March 2018 |
| Primary completion | 28 March 2022 |
| Estimated completion | 28 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Delta Dry® Waterproof Pantaloon
- Cotton Padding
Conditions studied
- Developmental Dysplasia of the Hip — all drugs for Developmental Dysplasia of the Hip →
Sponsor
Baylor College of Medicine
Who can join
Adults 0 to 5, any sex, with Developmental Dysplasia of the Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to: 1) investigate the effectiveness of waterproof spica cast using Delta-Dry® Pantaloon and cast padding (BSN medical, USA) versus standard gortex pantaloon with cotton cast padding in maintaining the femur fracture and developmental dysplasia of the hip reduction after application of hip spica; 2) evaluate the overall quality ratings of both cast paddings from the perspectives of the patient and the clinicians; and 3) determine the cost difference between the both cast paddings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03859232
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Dysplasia of the Hip
Currently open trials in the same condition.
- NCT06512506 — Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia · recruiting
- NCT04101903 — Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice · NA · active not recruiting
- NCT05186168 — Corin MiniHip and Trinity Cup Clinical Surveillance Study · active not recruiting
Other Baylor College of Medicine trials
Trials by the same sponsor.
- NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) · Phase 1 · not yet recruiting
- NCT05855824 — Toddler Biomarker of Nutrition Study · NA · not yet recruiting
- NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures · not yet recruiting
- NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital · Phase 2 · withdrawn
- NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03859232 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
- Last refreshed: 22 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859232.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing